National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01FA10	ZIMAX	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
L02BG04	FEMAZOL	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	1,433,432 L.L
M01AB55	DIFEN B12	G	Diclofenac sodium - 75mg, Prednisolone sodium phosphate - 10.08mg, Hydroxocobalamin acetate - 10.44mg		Injectable solution	978,317 L.L
N03AX14	LEVIPRAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,285,609 L.L
N06AA12	DOXEPIN HCl	G	Doxepin (HCl) - 10mg	10mg	Capsule	712,876 L.L
R06AE07	RINALGIT	G	Cetirizine (dihydrochloride) - 10mg/ml	10mg/ml	Drops solution	237,860 L.L
V07AB01	WATER FOR INJECTION/ DEMO	G	Water for injection -		Water for injection, irrigation	1,339,811 L.L
A06AB58	CITRAFLEET	G	Sodium picosulfate - 10mg/sachet, Magnesium oxide (light) - 3.5g/sachet, Citric acid (anhydrous) - 10.97g/sachet, Potassium - 195mg/sachet		Powder for solution	1,191,988 L.L
A10BD20	EMPAZIMET	G	Metformin HCl - 1000mg, Empagliflozin - 12.5mg		Tablet, film coated	1,840,168 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 15mg	15mg	Tablet, film coated	1,343,843 L.L
B05BC01	MANNITOL	G	Mannitol - 10g/100ml	10g/100ml	Injectable solution	329,815 L.L
C10AA05	LIPONORM	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	967,567 L.L
D07AC01	BETASONE	G	Betamethasone (valerate) - 1mg/g	1mg/g	Cream	120,306 L.L
G04BD08	URISOL	G	Solifenacin succinate - 5mg	5mg	Tablet, film coated	1,334,884 L.L
J01FA10	ZOMAX	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
L02BG04	LEFFTARA	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	2,060,111 L.L
M01AC01	PIROXICAM	G	Piroxicam - 10mg	10mg	Capsule	353,239 L.L
N01BB54	PRILA	G	Prilocaine - 2.5% w/w, Lidocaine - 2.5% w/w		Cream	1,057,604 L.L
N03AX14	KEPAM MS	G	Levetiracetam - 500mg/5ml	500mg/5ml	Injectable solution	9,170,015 L.L
N06AA12	DOXEPIN HCl	G	Doxepin (HCl) - 50mg	50mg	Capsule	965,007 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	155,886 L.L
V07AB01	WATER FOR INJECTION/ DEMO	G	Water for injection -		Water for injection, irrigation	1,103,295 L.L

National Cancer Registry (NCR)